Subcutaneous injection of RA into the dorsal skin of mice alleviates dibutyl square acid (SADBE)-induced pruritus and skin inflammation by inhibiting the MRGPRX2-PLCγ1PKC-NF-κB axis, which is involved in mast cell activation [35]. Here, MRGPRX2 is linked to dermatitis.